Cognitive Functioning in Vorinostat‐Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant

Key Points

• The research investigates the cognitive function of pediatric and young adult patients receiving vorinostat after hematopoietic stem cell transplant.
• Evaluated cognitive performance over 180 days post-transplant
• Assessed cognitive functioning prior to transplant
• Compared findings with adult population studies
• Identified cognitive impairments present prior to the transplant
• Demonstrated no additional cognitive deficits related to vorinostat treatment after transplant